NCCN Guidelines® Insights: Breast Cancer, Version 4.2021

Area of Science:

• Oncology
• Clinical Practice Guidelines

Background:

• The NCCN Guidelines for Breast Cancer provide comprehensive clinical management strategies.
• These guidelines cover various breast cancer types, including in situ, invasive, inflammatory, male, and pregnancy-associated breast cancer.
• Expert multidisciplinary panels develop and update these recommendations.

Purpose of the Study:

• To present the most recent updates to the NCCN Guidelines for Breast Cancer.
• Specifically focusing on adjuvant systemic therapy recommendations.
• Targeting patients with nonmetastatic, early-stage, hormone receptor-positive, HER2-negative breast cancer.

Main Methods:

• Development by a multidisciplinary panel of experts.
• Review of current evidence and clinical practice.
• Incorporation of recent advancements in breast cancer treatment.

Main Results:

• Updated recommendations for adjuvant systemic therapy.
• Focus on specific patient subgroup: early-stage, hormone receptor-positive, HER2-negative breast cancer.
• Guidelines address management of diverse breast cancer conditions.

Conclusions:

• The NCCN Guidelines provide essential, up-to-date information for breast cancer management.
• Recent updates offer refined strategies for adjuvant therapy in a key patient population.
• These guidelines support evidence-based, multidisciplinary care for breast cancer.